Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
2024 Rabbet Report: Risk Management and Automation Emerge as Top Priorities in Construction Finance
-
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
-
Intuitive Machines Reports First Quarter 2024 Financial Results; Provides 2024 Revenue Outlook
-
CEOs of Qualifacts and OPEN MINDS Join Forces to Discuss the Data-Driven Future of Behavioral Health
-
Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
-
Arctic Wolf Named to CNBC Disruptor 50 List for Third Consecutive Year
-
Scorpius Holdings, Inc. Announces Pricing of Public Offering
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
CryoMass Announces Sale of First Production Model to be deployed in Canada
-
Man Group PLC : Form 8.3 - Tyman plc
-
Crown Crafts Announces Quarterly Cash Dividend
-
KP Tissue Releases First Quarter 2024 Financial Results
-
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
-
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
-
Honey & Barry Sherman Legacy Foundation Donates $10 Million to Humber River Health Foundation
-
Sable Options Perk-Rocky Copper-Gold Porphyry Project in BC Canada
-
Forsys Reports Updated Mineral Resource Estimate for its Norasa Project in Namibia
-
Synlogic Reports First Quarter 2024 Financial Results
-
Progress of 2024 Drilling Program of the Cartier’s Chimo Mine Project
-
Azimut Updates on Surface Program Planned at Pilipas, James Bay Region, Quebec
-
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
-
Broadwind Announces First Quarter 2024 Results
-
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
-
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
-
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
-
MetaWorks' New Venture, Energy Works, Inc., to Revolutionize Plastic Waste Management with Cutting-Edge Diesel Fuel Conversion
-
Hydrofarm Holdings Group Announces First Quarter 2024 Results
-
Employ Welcomes New Chief Customer Officer
-
Troilus Announces Feasibility Study Results for the Gold-Copper Troilus Project: Outlines a Large Scale, 22-Year Open Pit Project in Tier-One Jurisdiction With USD$884.5 Million NPV(5%)
-
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024
-
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems
-
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
-
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
-
One in four US subscribers will sign up to a new streaming service to watch the Olympics
-
GXO Deploys First-of-its-kind Large-scale Robotics Solution in France
-
MetaWorks' New Venture, Energy Works, Inc., to Revolutionize Plastic Waste Management with Cutting-Edge Diesel Fuel Conversion
-
Harvard Business School publishes Kaspi.kz case study
-
MAG Silver Reports First Quarter Financial Results
-
Bitfarms Doubles Yguazu Power Capacity to 200 MW with Additional 100 MW of Hydropower in Paraguay
-
Hotel Equities Selected to Manage First Hampton by Hilton-Branded Hotel in St. Thomas, U.S. Virgin Islands
-
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
-
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
-
Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th
-
CareCloud Reports First Quarter 2024 Results
-
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
-
REGENESIS Named Winner of Fast Company’s 2024 World Changing Ideas Award
-
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
-
ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabling Advanced Gene Editing Techniques
-
Dave Ramsey’s “The Total Money Makeover” 20th Anniversary Edition Hits Shelves May 14


